Alkermes (ALKS) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Alkermes (ALKS) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: September 27, 2023 (12:35)

Sector: Healthcare

The share price of Alkermes plc (ALKS) now

What analysts predict: $36.67
52-week High/Low: $33.71 / $21.75

50/200 Day Moving Average: $29.29 / $28.63

This figure corresponds to the Average Price over the previous 50/200 days. For Alkermes stocks, the 50-day moving average is the resistance level today.

For Alkermes stocks, the 200-day moving average is the support level today.

Are you interested in Alkermes plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alkermes stock price in 2023, 2024, 2025, 2026, 2027. How much will one Alkermes share be worth in 2023 - 2027?

When should I take profit in Alkermes stock? When should I record a loss on Alkermes stock? What are analysts' forecasts for Alkermes stock? What is the future of Alkermes stock? We forecast Alkermes stock performance using neural networks based on historical data on Alkermes stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alkermes stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alkermes shares. This happens once a day.




Historical and forecast chart of Alkermes stock

The chart below shows the historical price of Alkermes stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alkermes stock price can be found in the table below.

Long-term forecasts by years.

Alkermes daily forecast for a month

Date Target Pes. Opt. Vol., %
Sep 29 29.53 29.10 29.91 2.76
Sep 30 29.62 29.31 30.10 2.68
Oct 01 28.99 28.55 29.53 3.41
Oct 02 28.20 28.01 28.85 3.00
Oct 03 27.90 27.65 28.08 1.55
Oct 04 28.16 27.68 28.78 3.97
Oct 05 28.21 27.91 28.82 3.27
Oct 06 27.92 27.53 28.25 2.60
Oct 07 28.60 28.07 29.00 3.29
Oct 08 28.24 27.52 28.44 3.32
Oct 09 27.63 27.08 27.88 2.94
Oct 10 27.47 27.15 27.68 1.97
Oct 11 27.09 26.79 27.31 1.94
Oct 12 27.07 26.68 27.63 3.57
Oct 13 27.10 26.67 27.62 3.58
Oct 14 27.76 27.33 28.26 3.41
Oct 15 27.94 27.51 28.40 3.22
Oct 16 28.57 27.87 28.94 3.84
Oct 17 27.87 27.45 28.23 2.83
Oct 18 27.51 27.01 28.07 3.91
Oct 19 27.64 27.18 27.89 2.60
Oct 20 26.81 26.30 27.05 2.84
Oct 21 27.22 26.81 27.43 2.31
Oct 22 28.00 27.39 28.50 4.02
Oct 23 27.65 27.07 27.85 2.88
Oct 24 27.85 27.28 28.12 3.10
Oct 25 27.20 26.68 27.87 4.44
Oct 26 27.43 27.13 28.10 3.56
Oct 27 27.34 26.95 27.97 3.80
Oct 28 26.68 26.10 26.93 3.17

Alkermes Daily Price Targets


Alkermes Stock Forecast 09-29-2023.

Forecast target price for 09-29-2023: $29.53.
Positive dynamics for Alkermes shares will prevail with possible volatility of 2.686%.
Pessimistic target level: 29.10
Optimistic target level: 29.91

Alkermes Stock Forecast 09-30-2023.

Forecast target price for 09-30-2023: $29.62.
Positive dynamics for Alkermes shares will prevail with possible volatility of 2.614%.
Pessimistic target level: 29.31
Optimistic target level: 30.10

Alkermes Stock Forecast 10-01-2023.

Forecast target price for 10-01-2023: $28.99.
Negative dynamics for Alkermes shares will prevail with possible volatility of 3.299%.
Pessimistic target level: 28.55
Optimistic target level: 29.53

Alkermes Stock Forecast 10-02-2023.

Forecast target price for 10-02-2023: $28.20.
Negative dynamics for Alkermes shares will prevail with possible volatility of 2.909%.
Pessimistic target level: 28.01
Optimistic target level: 28.85

Alkermes Stock Forecast 10-03-2023.

Forecast target price for 10-03-2023: $27.90.
Negative dynamics for Alkermes shares will prevail with possible volatility of 1.526%.
Pessimistic target level: 27.65
Optimistic target level: 28.08

Alkermes Stock Forecast 10-04-2023.

Forecast target price for 10-04-2023: $28.16.
Positive dynamics for Alkermes shares will prevail with possible volatility of 3.820%.
Pessimistic target level: 27.68
Optimistic target level: 28.78

ALKS (ALKS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Oct. 29.91 26.35 33.77 21.98
Nov. 29.25 25.92 31.63 18.08
Dec. 28.60 27.34 32.49 15.86

Alkermes forecast for this year


Alkermes Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $29.908. Pessimistic: $26.35. Optimistic: $33.77


Alkermes Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $29.247. Pessimistic: $25.92. Optimistic: $31.63


Alkermes Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $28.6007. Pessimistic: $27.34. Optimistic: $32.49



Alkermes (ALKS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 28.75 25.91 32.02 19.08
Feb 26.30 24.78 27.69 10.50
Mar 29.34 25.65 32.09 20.05
Apr 26.85 25.75 30.23 14.80
May 26.67 23.18 29.61 21.74
Jun 28.89 26.33 32.38 18.66
Jul 24.76 23.58 26.36 10.54
Aug 24.64 21.66 25.85 16.20
Sep 25.60 22.51 28.99 22.36
Oct 29.73 27.56 33.27 17.17
Nov 32.57 30.46 34.34 11.29
Dec 37.71 36.37 41.37 12.09

Alkermes (ALKS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 37.71 33.80 41.43 18.41
Feb 34.83 33.53 36.78 8.85
Mar 33.94 29.84 36.48 18.19
Apr 33.65 29.82 36.28 17.82
May 32.11 30.74 36.09 14.82
Jun 29.16 25.94 30.35 14.54
Jul 28.57 24.97 32.45 23.05
Aug 24.78 22.46 27.68 18.87
Sep 28.40 27.39 31.10 11.95
Oct 31.54 28.54 34.86 18.15
Nov 36.36 34.45 41.19 16.36
Dec 42.11 38.39 44.98 14.64

Alkermes (ALKS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 43.26 40.24 46.86 14.12
Feb 38.62 34.95 41.38 15.55
Mar 40.14 35.77 45.18 20.84
Apr 40.34 38.21 43.70 12.55
May 43.70 38.43 45.41 15.38
Jun 46.45 42.26 50.87 16.92
Jul 51.34 44.36 57.37 22.67
Aug 52.83 46.27 59.83 22.66
Sep 60.46 57.28 64.98 11.86
Oct 61.90 59.06 68.32 13.55
Nov 71.79 63.01 77.90 19.12
Dec 78.99 69.59 84.77 17.90

Alkermes (ALKS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 79.13 74.69 85.05 12.18
Feb 74.82 65.03 78.89 17.57
Mar 71.90 65.05 78.50 17.13
Apr 76.91 67.36 84.88 20.64
May 72.20 67.42 75.88 11.16
Jun 70.97 62.41 79.42 21.42
Jul 76.16 70.21 79.01 11.14
Aug 75.13 69.25 81.13 14.64
Sep 86.37 75.21 96.35 21.94
Oct 96.64 90.40 107.49 15.90
Nov 94.02 83.31 98.97 15.83
Dec 92.10 85.05 96.17 11.56

Alkermes information and performance

Alkermes plc is an Irish biopharmaceutical company that researches, develops and markets pharmaceutical products used in a variety of therapeutic areas around the world. The company’s products include drugs for the treatment of schizophrenia, schizoaffective, depressive and bipolar disorder, alcohol and opioid addiction, aids to improve walking in adults with multiple sclerosis, and a drug for the treatment of type 2 diabetes. The company serves pharmaceutical wholesalers, specialized pharmacies and distributors.

Alkermes Address

CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IE

Market Capitalization: 4 833 543 000 $

Market capitalization of the Alkermes plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALKS shares in the company outstanding by the market price of one share.

EBITDA: 187 475 000 $

EBITDA of Alkermes is earnings before interest, income tax and depreciation of assets.

PE Ratio: 51.82

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -1057.29

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.56

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 1.235
Trailing PE: 51.82

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 588.24

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.566

Enterprise Value (EV) /Revenue

EV To EBITDA: -72.85

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 166559000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.